WallStSmart

agilon health Inc (AGL)vsFresenius Medical Care Corporation (FMS)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Fresenius Medical Care Corporation generates 228% more annual revenue ($19.43B vs $5.92B). FMS leads profitability with a 4.8% profit margin vs -3.9%. FMS earns a higher WallStSmart Score of 58/100 (C).

AGL

Hold

41

out of 100

Grade: D

Growth: 8.7Profit: 2.5Value: 5.0Quality: 6.0
Piotroski: 3/9Altman Z: 1.54

FMS

Buy

58

out of 100

Grade: C

Growth: 4.7Profit: 5.0Value: 9.3Quality: 6.0
Piotroski: 6/9Altman Z: 1.96
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AGL.

FMSUndervalued (+68.2%)

Margin of Safety

+68.2%

Fair Value

$75.72

Current Price

$22.17

$53.55 discount

UndervaluedFair: $75.72Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AGL2 strengths · Avg: 9.5/10
EPS GrowthGrowth
301.0%10/10

Earnings expanding 301.0% YoY

Debt/EquityHealth
0.159/10

Conservative balance sheet, low leverage

FMS3 strengths · Avg: 9.3/10
P/E RatioValuation
10.9x10/10

Attractively priced relative to earnings

Price/BookValuation
0.8x10/10

Reasonable price relative to book value

PEG RatioValuation
0.728/10

Growing faster than its price suggests

Areas to Watch

AGL4 concerns · Avg: 3.3/10
Altman Z-ScoreHealth
1.544/10

Distress zone — elevated risk

Market CapQuality
$1.43B3/10

Smaller company, higher risk/reward

Operating MarginProfitability
1.3%3/10

Operating margin of 1.3%

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

FMS4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
1.4%4/10

1.4% revenue growth

Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Return on EquityProfitability
7.5%3/10

ROE of 7.5% — below average capital efficiency

Profit MarginProfitability
4.8%3/10

4.8% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : AGL

The strongest argument for AGL centers on EPS Growth, Debt/Equity.

Bull Case : FMS

The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.72 suggests the stock is reasonably priced for its growth.

Bear Case : AGL

The primary concerns for AGL are Altman Z-Score, Market Cap, Operating Margin.

Bear Case : FMS

The primary concerns for FMS are Revenue Growth, Altman Z-Score, Return on Equity. Thin 4.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

AGL profiles as a turnaround stock while FMS is a value play — different risk/reward profiles.

AGL carries more volatility with a beta of 3.00 — expect wider price swings.

AGL is growing revenue faster at 7.2% — sustainability is the question.

FMS generates stronger free cash flow (620M), providing more financial flexibility.

Bottom Line

FMS scores higher overall (58/100 vs 41/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

agilon health Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

agilon health, inc. The company is headquartered in Long Beach, California.

Visit Website →

Fresenius Medical Care Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.

Visit Website →

Want to dig deeper into these stocks?